Benefit of including CT urography in [68Ga]PSMA-11 PET/CT with low-dose CT: first results from a larger prostate cancer cohort analysis.

Rosar, Florian; Hügle, Martin J; Ries, Martin; Bartholomä, Mark; Maus, Stephan; Fries, Peter; Khreish, Fadi; Ezziddin, Samer

Rosar, Florian; Hügle, Martin J; Ries, Martin; Bartholomä, Mark; Maus, Stephan; Fries, Peter; Khreish, Fadi; Ezziddin, Samer.

Affiliation

Rosar F; Department of Nuclear Medicine, Saarland University Medical Center, Homburg, Germany - florian.rosar@uks.eu.
Hügle MJ; Department of Nuclear Medicine, Saarland University Medical Center, Homburg, Germany.
Ries M; Department of Nuclear Medicine, Saarland University Medical Center, Homburg, Germany.
Bartholomä M; Department of Nuclear Medicine, Saarland University Medical Center, Homburg, Germany.
Maus S; Department of Nuclear Medicine, Saarland University Medical Center, Homburg, Germany.
Fries P; Clinic of Diagnostic and Interventional Radiology, Saarland University Medical Center, Homburg, Germany.
Khreish F; Department of Nuclear Medicine, Saarland University Medical Center, Homburg, Germany.
Ezziddin S; Department of Nuclear Medicine, Saarland University Medical Center, Homburg, Germany.

Q J Nucl Med Mol Imaging ; 66(3): 280-289, 2022 Sep.

Article de En | MEDLINE | ID: mdl-31992688

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs de la prostate / Tomographie par émission de positons couplée à la tomodensitométrie Type d'étude: Guideline / Observational_studies / Prognostic_studies Limites: Humans / Male Langue: En Journal: Q J Nucl Med Mol Imaging Sujet du journal: MEDICINA NUCLEAR Année: 2022 Type de document: Article

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google